Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 7.82
(0.13%)
CNY 7.82
(0.13%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 253.9 Million CNY | 7.87% |
| 2022 | 235.37 Million CNY | 61.29% |
| 2021 | 145.93 Million CNY | 68.05% |
| 2020 | 86.83 Million CNY | 54.0% |
| 2019 | 56.38 Million CNY | 28.55% |
| 2018 | 43.86 Million CNY | -17.26% |
| 2017 | 53.01 Million CNY | -7.53% |
| 2016 | 57.32 Million CNY | -5.81% |
| 2015 | 60.86 Million CNY | 183.08% |
| 2014 | 21.5 Million CNY | 38.25% |
| 2013 | 15.55 Million CNY | 578.01% |
| 2012 | 2.29 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 67.35 Million CNY | -40.12% |
| 2024 Q1 | 112.48 Million CNY | 293.78% |
| 2024 Q3 | 49.15 Million CNY | -27.02% |
| 2023 Q2 | 66.52 Million CNY | -28.98% |
| 2023 Q3 | 65.14 Million CNY | -2.08% |
| 2023 FY | 253.9 Million CNY | 7.87% |
| 2023 Q1 | 93.67 Million CNY | 60.68% |
| 2023 Q4 | 28.56 Million CNY | -56.15% |
| 2022 Q4 | 58.29 Million CNY | 7.85% |
| 2022 Q2 | 52.3 Million CNY | -26.05% |
| 2022 Q1 | 70.72 Million CNY | 98.57% |
| 2022 FY | 235.37 Million CNY | 61.29% |
| 2022 Q3 | 54.05 Million CNY | 3.35% |
| 2021 Q2 | 38.8 Million CNY | -11.56% |
| 2021 FY | 145.93 Million CNY | 68.05% |
| 2021 Q1 | 43.87 Million CNY | 112.52% |
| 2021 Q4 | 35.61 Million CNY | 28.92% |
| 2021 Q3 | 27.62 Million CNY | -28.81% |
| 2020 Q3 | 13.59 Million CNY | -57.02% |
| 2020 Q2 | 31.61 Million CNY | 50.71% |
| 2020 FY | 86.83 Million CNY | 54.0% |
| 2020 Q1 | 20.97 Million CNY | 243.59% |
| 2020 Q4 | 20.64 Million CNY | 51.92% |
| 2019 Q3 | 19.24 Million CNY | -17.26% |
| 2019 Q2 | 23.25 Million CNY | 198.86% |
| 2019 Q1 | 7.78 Million CNY | -32.47% |
| 2019 FY | 56.38 Million CNY | 28.55% |
| 2019 Q4 | 6.1 Million CNY | -68.27% |
| 2018 Q1 | 2.01 Million CNY | -90.59% |
| 2018 Q3 | 8.6 Million CNY | -60.38% |
| 2018 Q2 | 21.72 Million CNY | 980.21% |
| 2018 FY | 43.86 Million CNY | -17.26% |
| 2018 Q4 | 11.52 Million CNY | 33.9% |
| 2017 FY | 53.01 Million CNY | -7.53% |
| 2017 Q3 | 7.06 Million CNY | -43.72% |
| 2017 Q2 | 12.54 Million CNY | 4.26% |
| 2017 Q1 | 12.03 Million CNY | -49.01% |
| 2017 Q4 | 21.37 Million CNY | 202.69% |
| 2016 Q1 | 11.44 Million CNY | 0.0% |
| 2016 Q3 | 13.56 Million CNY | 55.5% |
| 2016 Q2 | 8.72 Million CNY | -23.83% |
| 2016 Q4 | 23.59 Million CNY | 74.03% |
| 2016 FY | 57.32 Million CNY | -5.81% |
| 2015 FY | 60.86 Million CNY | 183.08% |
| 2015 Q1 | 9.95 Million CNY | 0.0% |
| 2014 FY | 21.5 Million CNY | 38.25% |
| 2013 FY | 15.55 Million CNY | 578.01% |
| 2012 FY | 2.29 Million CNY | 0.0% |